Biotest Aktiengesellschaft (HAM:BIO3)

HAM:BIO3 Revenue

Biotest Aktiengesellschaft had revenue of 124.20M EUR in the quarter ending March 31, 2025, a decrease of -42.29%. This brings the company's revenue in the last twelve months to 635.20M, down -18.83% year-over-year. In the year 2024, Biotest Aktiengesellschaft had annual revenue of 726.20M with 6.08% growth.

• Revenue (ttm): 635.20M
• Revenue Growth: -18.83%
• P/S Ratio: 2.20
• Revenue / Employee: 254.59K
• Employees: 2,495
• Market Cap: 1.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	726.20M	41.60M	6.08%
Dec 31, 2023	684.60M	168.50M	32.65%
Dec 31, 2022	516.10M	500.00K	0.10%
Dec 31, 2021	515.60M	31.40M	6.48%
Dec 31, 2020	484.20M	65.10M	15.53%